EDAP TMS SA (EDAP), a provider of therapeutic ultrasound, Tuesday said it received CE Mark for Focal.One, its new and innovative robotic HIFU device fully dedicated to focal therapy of prostate cancer.
Focal.One was showcased as world premiere at the European Urology Association Congress in Milan, Italy on March 15-19.
Focal.One is the first device fully dedicated to the focal approach for prostate cancer therapy. It combines the three essential components to efficiently perform a focal treatment.
Marc Oczachowski, Chief Executive Officer of EDAP TMS, said,''Combining into one unique HIFU device the latest imaging modalities, such as MRI localization and contrast-enhanced ultrasound control, with the ultimate dynamic focusing HIFU technology, Focal.One will offer an optimal focal therapy of prostate cancer while preserving patient quality of life."
For comments and feedback: editorial@rttnews.com